UK’s private GP EHR market is expected to grow from 2023 to 2028, according to ResearchAndMarkets’ latest report. The demand is driven by the increasing need for improved patient care, regulatory compliance, and the rising popularity of private GP services. Technical restraints and privacy concerns linked to cyber-attacks and data security could, however, limit the market growth.
Vertex Pharma’s Growth Strategy Leads to Its Biggest-Ever M&A Deal
Vertex Pharmaceuticals’ acquisition of Crinetics Pharmaceuticals values the company at about $10 billion. Crinetics’s Palsonify could become a new standard of care therapy for acromegaly
